EQ: Equillium Inc. Stocks News on November 19, 2025

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

EQ

GlobeNewswire

6 days ago

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

Equillium to Participate in Upcoming Investor Conferences

EQ

GlobeNewswire

15 days ago

Equillium to Participate in Upcoming Investor Conferences

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EQ

GlobeNewswire

16 days ago

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025

EQ

GlobeNewswire

a month ago

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025

Equillium Announces Leadership and Corporate Updates

EQ

GlobeNewswire

a month ago

Equillium Announces Leadership and Corporate Updates

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

EQ

Business Wire

6 months ago

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

EQ

Business Wire

7 months ago

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Equillium Announces Feedback from the U.S. Food and Drug Administration

EQ

Business Wire

7 months ago

Equillium Announces Feedback from the U.S. Food and Drug Administration

Promising Penny Stocks To Consider In April 2025

EQ

Simply Wall St.

7 months ago

Promising Penny Stocks To Consider In April 2025

Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

EQ

Zacks

8 months ago

Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Equillium Full Year 2024 Earnings: Beats Expectations

EQ

Simply Wall St.

8 months ago

Equillium Full Year 2024 Earnings: Beats Expectations

EQ

MT Newswires

8 months ago

Leerink Partners Downgrades Equillium to Market Perform From Outperform, Adjusts Price Target to $1 From $3

Equillium pushes for breakthrough status despite missing primary endpoint

EQ

Clinical Trials Arena

8 months ago

Equillium pushes for breakthrough status despite missing primary endpoint

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

EQ

Business Wire

8 months ago

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

EQ

Business Wire

8 months ago

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?

EQ

Zacks

8 months ago

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?

Here's Why Equillium (EQ) Is a Great 'Buy the Bottom' Stock Now

EQ

Zacks

9 months ago

Here's Why Equillium (EQ) Is a Great 'Buy the Bottom' Stock Now

Equillium (EQ) Upgraded to Buy: Here's What You Should Know

EQ

Zacks

9 months ago

Equillium (EQ) Upgraded to Buy: Here's What You Should Know

Equillium (EQ) Shows Fast-paced Momentum But Is Still a Bargain Stock

EQ

Zacks

9 months ago

Equillium (EQ) Shows Fast-paced Momentum But Is Still a Bargain Stock

CuriosityStream And 2 Other Promising Penny Stocks On US Exchange

EQ

Simply Wall St.

9 months ago

CuriosityStream And 2 Other Promising Penny Stocks On US Exchange

Equillium Reports Positive Phase 2 Results for Itolizumab in Ulcerative Colitis, Shares Surge

EQ

GuruFocus.com

9 months ago

Equillium Reports Positive Phase 2 Results for Itolizumab in Ulcerative Colitis, Shares Surge

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

EQ

Business Wire

9 months ago

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

US Penny Stocks To Watch In January 2025

EQ

Simply Wall St.

a year ago

US Penny Stocks To Watch In January 2025

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

EQ

Business Wire

a year ago

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference

EQ

Business Wire

a year ago

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

EQ

Business Wire

a year ago

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

EQ

Zacks

a year ago

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

EQ

MT Newswires

a year ago

Sector Update: Health Care Stocks Softer Late Afternoon

EQ

MT Newswires

a year ago

Top Midday Decliners

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates

EQ

Zacks

a year ago

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates

Equillium Maintains Rights to Itolizumab Following Ono Partnership

EQ

Business Wire

a year ago

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Alto Ingredients And 2 Other US Penny Stocks To Watch Closely

EQ

Simply Wall St.

a year ago

Alto Ingredients And 2 Other US Penny Stocks To Watch Closely

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

EQ

Business Wire

a year ago

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy

EQ

Pharmaceutical Technology

a year ago

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

EQ

Business Wire

a year ago

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EQ

Business Wire

a year ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

EQ

Business Wire

a year ago

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

Equillium Second Quarter 2024 Earnings: Beats Expectations

EQ

Simply Wall St.

a year ago

Equillium Second Quarter 2024 Earnings: Beats Expectations

Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates

EQ

Zacks

a year ago

Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

EQ

Business Wire

a year ago

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

EQ

Business Wire

a year ago

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

EQ

Business Wire

a year ago

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

EQ

Business Wire

a year ago

Equillium to Participate in Upcoming Investor Conferences

Equillium to be included in the Russell Microcap® Index

EQ

Business Wire

a year ago

Equillium to be included in the Russell Microcap® Index

EQ

Motley Fool

a year ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

EQ

Motley Fool

a year ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

EQ

Motley Fool

a year ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

EQ

AFP

a year ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

EQ

Motley Fool

a year ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

EQ

GuruFocus.com

a year ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

EQ

GuruFocus.com

a year ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

EQ

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

EQ

Business Wire

a year ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

EQ

Business Wire

a year ago

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

Equillium to Present at the Jefferies Global Healthcare Conference

EQ

Business Wire

a year ago

Equillium to Present at the Jefferies Global Healthcare Conference

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

EQ

Business Wire

2 years ago

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates

EQ

Zacks

2 years ago

Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

EQ

Business Wire

2 years ago

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

EQ

Business Wire

2 years ago

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate

EQ

Simply Wall St.

2 years ago

We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate

EQ

Business Wire

2 years ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 Stocks That More Than Doubled in Q1 With More Gains Ahead

EQ

Zacks

2 years ago

5 Stocks That More Than Doubled in Q1 With More Gains Ahead

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

EQ

Business Wire

2 years ago

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates

EQ

Zacks

2 years ago

Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

EQ

Business Wire

2 years ago

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference

EQ

Business Wire

2 years ago

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference

Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20%

EQ

Simply Wall St.

2 years ago

Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20%

EQ

Zacks

2 years ago

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

5 Stocks That More Than Doubled in February

EQ

Zacks

2 years ago

5 Stocks That More Than Doubled in February

5 Top-Ranked Stocks That Have More Than Doubled Year to Date

EQ

Zacks

2 years ago

5 Top-Ranked Stocks That Have More Than Doubled Year to Date

Even after rising 85% this past week, Equillium (NASDAQ:EQ) shareholders are still down 85% over the past three years

EQ

Simply Wall St.

2 years ago

Even after rising 85% this past week, Equillium (NASDAQ:EQ) shareholders are still down 85% over the past three years

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

EQ

Insider Monkey

2 years ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

EQ

Associated Press Finance

2 years ago

Territorial Bancorp: Q4 Earnings Snapshot

Territorial Bancorp Inc. Declares Dividend

EQ

GlobeNewswire

2 years ago

Territorial Bancorp Inc. Declares Dividend

Optex Systems Announces Acquisition of Speedtracker

EQ

ACCESSWIRE

2 years ago

Optex Systems Announces Acquisition of Speedtracker

EQ

Business Wire

2 years ago

Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

EQ

GlobeNewswire

2 years ago

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

EQ

Business Wire

2 years ago

Coya Therapeutics Announces Pipeline Expansion of COYA 302 to Include Frontotemporal Dementia and Parkinson’s Disease in Addition to Amyotrophic Lateral Sclerosis

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

EQ

Business Wire

2 years ago

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

EQ

PR Newswire

2 years ago

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Investors in Barnes & Noble Education (NYSE:BNED) from five years ago are still down 65%, even after 19% gain this past week

EQ

Simply Wall St.

2 years ago

Investors in Barnes & Noble Education (NYSE:BNED) from five years ago are still down 65%, even after 19% gain this past week

Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation

EQ

GlobeNewswire

2 years ago

Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

EQ

GlobeNewswire

2 years ago

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

EQ

PR Newswire

2 years ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

EQ

GlobeNewswire

2 years ago

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

EQ

InvestorPlace

2 years ago

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

EQ

GlobeNewswire

2 years ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

5 Top Energy Growth Stocks That You Need to Buy for 2024

EQ

Zacks

2 years ago

5 Top Energy Growth Stocks That You Need to Buy for 2024

EQ

GlobeNewswire

2 years ago

NSTS Bancorp Announces Balance Sheet Repositioning

EQ

GlobeNewswire

2 years ago

NSTS Bancorp Announces Authorization of Stock Repurchase Program

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

EQ

Business Wire

2 years ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

3 AI Stocks I Wouldn’t Touch With a 10-Foot Pole

EQ

InvestorPlace

2 years ago

3 AI Stocks I Wouldn’t Touch With a 10-Foot Pole

EQ

Associated Press Finance

2 years ago

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

EQ

GlobeNewswire

2 years ago

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

FiscalNote Announces Strategic Commercial Partnership to Accelerate Company’s Global AI Co-pilot Program

EQ

Business Wire

2 years ago

FiscalNote Announces Strategic Commercial Partnership to Accelerate Company’s Global AI Co-pilot Program

$Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)$

EQ

GlobeNewswire

2 years ago

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)

Eagle Bancorp Montana, Inc. (NASDAQ:EBMT) most popular amongst retail investors who own 55% of the shares, institutions hold 38%

EQ

Simply Wall St.

2 years ago

Eagle Bancorp Montana, Inc. (NASDAQ:EBMT) most popular amongst retail investors who own 55% of the shares, institutions hold 38%

Outlook Therapeutics® Announces Strategic Organizational Realignment

EQ

GlobeNewswire

2 years ago

Outlook Therapeutics® Announces Strategic Organizational Realignment

Globalink Investment Inc. Announces Charter and Trust Agreement Amendments

EQ

GlobeNewswire

2 years ago

Globalink Investment Inc. Announces Charter and Trust Agreement Amendments

EQ

Business Wire

2 years ago

Latest Equillium Inc. (EQ) News on November 19, 2025

Share on Social Networks: